Acquisition announcements typically lead to a rise in the stock price of the company being acquired. This is due to the perceived increase in value and potential future growth. In this case, Zynerba Pharmaceuticals is being acquired by Harmony Biosciences, which has led to a surge in Zynerba's share prices.